Company Overview of Igenica, Inc.
Igenica, Inc., a biopharmaceutical company, engages in the discovery and development of antibody-based therapeutics for the treatment of cancer. It develops recombinant monoclonal antibodies and treatments for multiple oncology indications. The company was founded in 2008 and is based in Burlingame, California.
863 Mitten Road
Burlingame, CA 94010
Founded in 2008
Key Executives for Igenica, Inc.
Igenica, Inc. Key Developments
Similar Private Companies By Industry
|CeraPedics, Inc.||United States|
|Molecular Diagnostics & Therapeutics Inc.||United States|
|Biovest International Inc.||United States|
|Immunotope, Inc.||United States|
|Cognetix, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- San Mateo, CA |Posted: Apr 05
- San Francisco, CA | Investment Firm Providing Private and Institutional BrokeragePosted: Apr 07
- Kansas City, MO | SkillsniperPosted: Apr 14
- New York | Leading Financial Institution of CanadaPosted: Mar 05
Sponsored Financial Commentaries
To contact Igenica, Inc., please visit www.igenica.com. Company data is provided by Capital IQ. Please use this form to report any data issues.